-transparent.png){kind=logo}
Arabinogalactan purified from heat-killed tubercle bacilli failed to elicit a delayed type of skin reaction and had no ability to induce in vitro lymphocyte blast formation in sensitized guinea pigs. It was, however, inhibitory to migration of bronchoalveolar washing cells by the indirect test, but not by the direct test, and capable of eliciting an immediate type of skin reaction and anaphylaxis when injected into sensitized guinea pigs. Tuberculin active peptide (TAP) was active in all of in vitro and in vivo cell-mediated immune responses, but not in immediate responses.
Related Publications
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
November 1970,
Science (New York, N.Y.),
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
June 1971,
Japanese journal of medical science & biology,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
October 1971,
Nature: New biology,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
July 1971,
Journal of immunology (Baltimore, Md. : 1950),
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
May 1968,
The American review of respiratory disease,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
January 1977,
Microbiology and immunology,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
July 1974,
Japanese journal of microbiology,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
February 1960,
Biochimica et biophysica acta,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
September 1971,
Klinische Wochenschrift,
T Niinaka, and
S Kishimoto, and
T Aoki, and
H Ikegami, and
F Ito
July 1958,
The Journal of experimental medicine,
